Conditional Deletion of Neuronal Cyclin-Dependent Kinase 5 in Developing Forebrain Results in Microglial Activation and Neurodegeneration
- 1 January 2010
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 176 (1) , 320-329
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 41 references indexed in Scilit:
- The Neuronal Expression of MYC Causes a Neurodegenerative Phenotype in a Novel Transgenic MouseThe American Journal of Pathology, 2009
- Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage.2003
- Cell Type-Specific Roles for Tissue Plasminogen Activator Released by Neurons or Microglia after Excitotoxic InjuryJournal of Neuroscience, 2003
- Tau Phosphorylation by Cyclin-dependent Kinase 5/p39 during Brain Development Reduces Its Affinity for MicrotubulesJournal of Biological Chemistry, 2003
- Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic InterventionThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Cyclin-Dependent Kinase 5/p35 Contributes Synergistically with Reelin/Dab1 to the Positioning of Facial Branchiomotor and Inferior Olive Neurons in the Developing Mouse HindbrainJournal of Neuroscience, 2002
- Tissue Plasminogen Activator Mediates Microglial Activation via Its Finger Domain through Annexin IIJournal of Neuroscience, 2002
- Cyclin‐dependent kinase 5 prevents neuronal apoptosis by negative regulation of c‐Jun N‐terminal kinase 3The EMBO Journal, 2002
- Cdk5 on the brain.2001
- Serial analysis of gene expression in a microglial cell lineGlia, 1999